Deconstructing the molecular portraits of breast cancer.

Mol Oncol · 2011 · PMC5528267 · PMID 21147047

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In this data set, Claudin‐low tumors showed a trend towards a lower pathological complete response (pCR) rate after anthracycline/taxane‐based chemotherapy compared to Basal‐like tumors (39% vs. 73% pCR rates, Figure 5 A), but their pCR rate was significantly higher than Luminal A (0%) or B (19%) tumors.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.